Study to Assess the Safety and Effects of Autologous Adipose-Derived Stem Cells in Patients With Frailty Syndrome

Exclusion Criteria

• •Life expectancy \< 6 months due to concomitant illnesses.
• •Exposure to any investigational drug or procedure within 1 month prior to study entry or enrolled in a concurrent study that may confound results of this study.
• •Active infectious disease patients known to have tested positive for HIV, HTLV, HBV, HCV, CMV (IgM \> IgG) and/or syphilis. will have an expert consulted as to patient eligibility based on the patient's infectious status
• •Any illness which, in the Investigator's judgment, will interfere with the patient's ability to comply with the protocol, compromise patient safety, or interfere with the interpretation of the study results
• •Patients on chronic immunosuppressive transplant therapy
• •Active clinical infection being treated by antibiotics within one week of enrollment.
• •Known drug or alcohol dependence or any other factors which will interfere with the study conduct or interpretation of the results or who in the opinion of the investigator are not suitable to participate.
• •History of cancer (other than non-melanoma skin cancer or in-situ cervical cancer) in the last five years.
• •Unwilling and/or not able to give written informed consent.